Zuclopenthixol-d4 succinate salt

Modify Date: 2024-01-12 17:27:58

Zuclopenthixol-d4 succinate salt structure	Common Name	Zuclopenthixol-d4 succinate salt
	CAS Number	1246833-97-5	Molecular Weight	523.08
	Density	N/A	Boiling Point	N/A
	Molecular Formula	C₂₆H₂₇D₄ClN₂O₅S	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of Zuclopenthixol-d4 succinate salt

Zuclopenthixol-d4((Z)-Clopenthixol-d4) succinate salt is the deuterium labeled Zuclopenthixol. Zuclopenthixol is a thioxanthene derivative which acts as a mixed dopamine D1/D2 receptor antagonist[1][2].

Name	Zuclopenthixol-d4 succinate salt

Description	Zuclopenthixol-d4((Z)-Clopenthixol-d4) succinate salt is the deuterium labeled Zuclopenthixol. Zuclopenthixol is a thioxanthene derivative which acts as a mixed dopamine D1/D2 receptor antagonist[1][2].
Related Catalog	Signaling Pathways >> GPCR/G Protein >> Dopamine Receptor Signaling Pathways >> Neuronal Signaling >> Dopamine Receptor Research Areas >> Neurological Disease
In Vitro	Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].
References	[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. [2]. Manzaneque JM, et al. An ethopharmacological assessment of the effects of zuclopenthixol on agonistic interactions in male mice. Methods Find Exp Clin Pharmacol. 1999 Jan-Feb;21(1):11-5. [3]. Khalifa AE, et al. Pro-oxidant activity of zuclopenthixol in vivo: differential effect of the drug on brain oxidative status of scopolamine-treated rats. Hum Exp Toxicol. 2004 Aug;23(9):439-45.

Molecular Formula	C₂₆H₂₇D₄ClN₂O₅S
Molecular Weight	523.08